Improvement Across Signs and Symptoms of Atopic Dermatitis with Lebrikizumab Use: Results from Two Phase 3, Randomized, Double-Blinded, Placebo-Controlled Monotherapy Trials (ADvocate 1 and 2)
Authors: Pablo Fernández-Peñas, Eric Simpson, Jacob P. Thyssen, Marjolein de Bruin-Weller, Peter Lio, Chia-Yu Chu, Helena Agell Gimeno, Marta Casillas, Yuxin Ding, Fan Emily Yang, Evangeline Pierce, Thomas Bieber
